Patient Guide: Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 15 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06675864
Status: 🟢 Enrolling Now
Condition: Progressive Multiple Sclerosis
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 15 locations across the country.

Top locations include:
  • • Darlinghurst, New South Wales
  • • Melbourne, Victoria
  • • Quebec,
  • • And 12 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS) - Join Clinical Trial NCTNCT06675864

How to Join This Clinical Trial - NCTNCT06675864

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Progressive Multiple Sclerosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Progressive Multiple Sclerosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Progressive Multiple Sclerosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06675864 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 15 locations. Find a study site near you:

Clinical Research Site

Darlinghurst, New South Wales 2010 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 3004 - Australia

Status: RECRUITING

Clinical Research Site

Quebec, G1J 1Z4 - Canada

Status: RECRUITING

Clinical Research Site

Montpellier, 34090 - France

Status: RECRUITING

Clinical Research Site

Nancy, 54035 - France

Status: RECRUITING

Clinical Research Site

Rennes, 35000 - France

Status: RECRUITING

Clinical Research Site

Essen, 45147 - Germany

Status: RECRUITING

Clinical Research Site

Ulm, 89081 - Germany

Status: RECRUITING

Clinical Research Site

Genova, GE 16132 - Italy

Status: RECRUITING

Clinical Research Site

Milano, MI 20132 - Italy

Status: RECRUITING

And 5 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Progressive Multiple Sclerosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships